Medical News

RSS

Role of beta defensins in development of chronic inflammatory response in the brain

Researchers at the Case Western Reserve University School of Dental Medicine and School of Medicine will look for evidence within the brain for human beta defensin peptide function-proteins important to the peripheral body's natural defense system against infection from the outside environment.

8 Apr 2010

Researchers identify major indicator of heart failure and aortic aneurysms

Case Western Reserve University School of Medicine researchers have identified a major indicator of two deadly diseases of the heart and blood vessels: heart failure and aortic aneurysm. The absence of the Kruppel-like Factor 15, when combined with stress, leads to both heart failure and aortic aneurysms.

8 Apr 2010

Americans are getting heavier younger and carrying extra weight for longer periods: Study

It was a provocative prediction that due to the obesity epidemic Baby Boomers may outlive their children.

8 Apr 2010

Cempra Pharmaceuticals announces schedule of poster presentations at ECCMID 2010

Cempra Pharmaceuticals today announced its schedule of poster presentations at the 20th European Congress of Clinical Microbiology and Infectious Disease (ECCMID) in Vienna, Austria, on April 10-13, 2010.

8 Apr 2010

Date set for NMT's Annual Meeting of Stockholders

Noninvasive Medical Technologies, Inc., an award-winning company engaged in pioneering highly advanced remote patient monitoring solutions, today announced that its Board of Directors has set the date of the Company's Annual Meeting of Stockholders for Wednesday, May 19, 2010.

8 Apr 2010

USPTO allows Alnylam Pharmaceuticals' new claims from Woppmann et al. patent series

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent Office (USPTO) has allowed a patent (Application No. 10/560,336) for the Woppmann et al. patent series, entitled "Double-stranded ribonucleic acid with increased effectiveness in an organism." The newly allowed patent includes 31 claims broadly covering compositions and methods, including pharmaceutical compositions, for small interfering RNAs (siRNAs), the molecules that mediate RNAi.

8 Apr 2010

Researchers document the beneficial health effects of omega-3 fatty acids

The health benefits of omega-3 fatty acids are widely proven. But how can these nutrients be absorbed most effectively into the body? And do they have any potentially negative effects? Norwegian researchers are seeking answers to these questions.

8 Apr 2010

Obstructive sleep apnea more than doubles stroke risk in men

Obstructive sleep apnea (OSA) is associated with an increased risk of stroke in middle-aged and older adults, especially men, according to new results from new research supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Overall, sleep apnea more than doubles the risk of stroke in men.

8 Apr 2010

New strategies to help allergy sufferers survive the winds of spring, summer

Every spring and summer, millions of Americans dread the trip to the park, the playground, or participating in any of the myriad activities that trigger outdoor allergy symptoms.

8 Apr 2010

Common myths about teens dispelled

The new book, The Teen Years Explained: A Guide to Healthy Adolescent Development, dispels many common myths about adolescence with the latest scientific findings on the physical, emotional, cognitive, sexual and spiritual development of teens. Authors Clea McNeely and Jayne Blanchard from the Center for Adolescent Health at the Johns Hopkins Bloomberg School of Public Health, provide useful tips and strategies for real-life situations and experiences from bullying, to nutrition and sexuality.

8 Apr 2010

Synta Pharmaceuticals to present posters on STA-9090 and elesclomol at AACR 2010

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Synta will present multiple posters at the American Association for Cancer Research 101st Annual Meeting 2010 to be held April 17-21, 2010 in Washington, DC.

8 Apr 2010

ADDF, AFTD announce recipients of Frontotemporal Dementia Drug Discovery Program award

The Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Dementias (AFTD) announced today the recipients of their third annual research award, Frontotemporal Dementia Drug Discovery Program. The goal of the program is to accelerate the development of novel therapies for frontotemporal dementia (FTD). The program will provide a total of $1,200,000 in research grants over four years.

8 Apr 2010

Data shows U.S. teen birth rate declined 2% in 2008

The nation's teen birth rate declined 2% in 2008, according to data released today by the Centers for Disease Control and Prevention's National Center for Health Statistics. After declining every year between 1991 and 2005, the teen birth rate increased 5% between 2005 and 2007 and is now on the decline again.

8 Apr 2010

LSDF announces $15M in program grant to enhance diagnosis and treatment of cancer

The Life Sciences Discovery Fund today announced nearly $15 million in program grant awards to support collaborative research initiatives spearheaded by three Washington state life sciences organizations.

8 Apr 2010

UTHealth awarded $15.3M for establishing HIT REC

The U.S. Department of Health and Human Services announced today that The University of Texas Health Science Center at Houston (UTHealth) has been awarded $15.3 million to establish a Health Information Technology Regional Extension Center (REC).

8 Apr 2010

SIR, Custom Computer Specialists sign licensing agreement to promote development of HI-IQ

The Society of Interventional Radiology and Custom Computer Specialists Inc. have entered into an exclusive, long-term licensing agreement to promote innovation and the development of HI-IQ-, the leading information management system for interventional radiology.

8 Apr 2010

Creation of Healthcare Virtual Career Platform: Competition for $13.2M in grant funds

U.S. Department of Labor today announced a competition for approximately $13.2 million in grant funds under the American Recovery and Reinvestment Act to create and implement a virtual service-delivery platform and promote career exploration in the healthcare sector.

8 Apr 2010

UNC Charlotte researcher improves lives of families and children affected by birth defects

Birth defects remain a leading cause of death in the first year of life. According to the March of Dimes, every 3 to 4 minutes a baby is born with a birth defect in the United States. About 1 in every 33 infants is affected by birth defects.

8 Apr 2010

OSU-CG12 agent kills cancer cells through energy restriction: Study

Cancer cells grow so fast that they can outstrip their blood supply, leaving them short of oxygen. The cells then produce energy in a way that needs less oxygen but more sugar.

8 Apr 2010

Phase III trial of brentuximab vedotin for post-transplant Hodgkin lymphoma initiated

Seattle Genetics, Inc., Takeda Pharmaceutical Company Limited and its wholly owned subsidiary Millennium: The Takeda Oncology Company today announced the initiation of a phase III clinical trial of brentuximab vedotin (SGN-35) for post-transplant Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) targeted to CD30, which is expressed on malignant Hodgkin lymphoma cells.

8 Apr 2010

Medical News

Role of beta defensins in development of chronic inflammatory response in the brain

Researchers identify major indicator of heart failure and aortic aneurysms

Americans are getting heavier younger and carrying extra weight for longer periods: Study

Cempra Pharmaceuticals announces schedule of poster presentations at ECCMID 2010

Date set for NMT's Annual Meeting of Stockholders

USPTO allows Alnylam Pharmaceuticals' new claims from Woppmann et al. patent series

Researchers document the beneficial health effects of omega-3 fatty acids

Obstructive sleep apnea more than doubles stroke risk in men

New strategies to help allergy sufferers survive the winds of spring, summer

Common myths about teens dispelled

Synta Pharmaceuticals to present posters on STA-9090 and elesclomol at AACR 2010

ADDF, AFTD announce recipients of Frontotemporal Dementia Drug Discovery Program award

Data shows U.S. teen birth rate declined 2% in 2008

LSDF announces $15M in program grant to enhance diagnosis and treatment of cancer

UTHealth awarded $15.3M for establishing HIT REC

SIR, Custom Computer Specialists sign licensing agreement to promote development of HI-IQ

Creation of Healthcare Virtual Career Platform: Competition for $13.2M in grant funds

UNC Charlotte researcher improves lives of families and children affected by birth defects

OSU-CG12 agent kills cancer cells through energy restriction: Study

Phase III trial of brentuximab vedotin for post-transplant Hodgkin lymphoma initiated

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News